Predict your next investment

Vapogenix company logo
HEALTHCARE | Drug Development
vapogenix.com

See what CB Insights has to offer

Stage

Unattributed VC | Alive

Total Raised

$18.83M

Last Raised

$1.63M | 4 yrs ago

About Vapogenix

Vapogenix is an early stage company focused on developing novel, non-opioid analgesics for acute and chronic pain management. Vapogenix's licensed technology covers novel formulations of known medications through new routes of administration for new indications, with the aim of creating potent analgesic and anti-inflammatory drugs. The company's lead product, VPX-595, is a compound being developed initially for the treatment of acute pain.

Vapogenix Headquarter Location

8285 El Rio St Suite 17

Houston, Texas, 77054,

United States

713-748-3903

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Vapogenix

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Vapogenix is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Vapogenix Patents

Vapogenix has filed 6 patents.

The 3 most popular patent topics include:

  • Analgesics
  • Anesthesia
  • NMDA receptor antagonists
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/14/2018

3/2/2021

Autoimmune diseases, Inflammations, NMDA receptor antagonists, Rare diseases, Syndromes

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/14/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

3/2/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Autoimmune diseases, Inflammations, NMDA receptor antagonists, Rare diseases, Syndromes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Vapogenix Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Vapogenix Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.